Showing results (41-50 of 73) with videos related to
Sort By:
Pageof 8
Arteriosclerosis, Thrombosis, and Vascular Biology|July 1, 1997
Modulation of tissue factor protein expression in experimental venous bypass graftsK M Channon, G J Fulton, M G Davies, et al.Arteriosclerosis and Thrombosis : a Journal of Vascular Biology|June 1, 1993
Potentiation of the vasospastic response to angioplasty by pretreatment with fluoxetine. A study in the atherosclerotic rabbitS L Sigal, J Gellman, G M Anderson, et al.Circulation|May 15, 1996
Monoclonal antibody against tissue factor shortens tissue plasminogen activator lysis time and prevents reocclusion in a rabbit model of carotid artery thrombosisM Ragni, P Cirillo, I Pascucci, et al.Circulation|October 27, 1998
Enhanced monocyte tissue factor response after experimental balloon angioplasty in hypercholesterolemic rabbit: inhibition with dietary L-arginineD Corseaux, T Le Tourneau, I Six, et al.Journal of Cardiovascular Pharmacology and Therapeutics|July 14, 2001
Exercise tolerance and quality of life in elderly patients with chronic atrial fibrillationC J Howes, M C Reid, C Brandt, et al.Journal of General Internal Medicine|August 1, 1998
Impact of gowning on visit length and physical examinationsD A Nardone, K E James, L FinckThe American Journal of Cardiology|July 1, 1984
Double-blind, placebo-controlled trial of propranolol given once, twice and four times daily in stable angina pectoris: a multicenter study using serial exercise testingG A Beller, N Bittar, J B Coelho, et al.Transfusion|January 1, 1987
In vitro characteristics and in vivo viability of platelets contained in granulocyte-platelet apheresis concentrateE L Snyder, M D Ezekowitz, H L Malech, et al.Circulation|October 1, 1978
Isolated drainage of the superior vena cava into the left atrium in a 52-year-old man: a rare congenital malformation in the adult presenting with cyanosis, polycythemia, and an unsuccessful lung scanM D Ezekowitz, P O Alderson, B H Bulkley, et al.Journal of Thrombosis and Haemostasis : JTH|October 7, 2011
Population pharmacokinetic analysis of the oral thrombin inhibitor dabigatran etexilate in patients with non-valvular atrial fibrillation from the RE-LY trialK-H Liesenfeld, T Lehr, C Dansirikul, et al.Pageof 8